Kexing Biopharm Co., Ltd.

This study tests a new growth hormone medicine (GB06) in 192 children aged 3 to 11 who have growth hormone deficiency, meaning they grow slower than normal. The goal is to see if GB06 works as well as an approved growth hormone to increase height over one year. Children will rece…

This early-stage study tests an experimental drug called GB18 in cancer patients who are losing weight and muscle (cachexia). The drug is designed to improve appetite and stop weight loss by blocking a specific protein. About 18 to 36 adults with advanced solid tumors will receiv…